Arianna is an Emergency and Addiction Medicine PA with more than 26 years of clinical experience. She works in Emergency and Addiction Psychiatry with an administrative role in buprenorphine access for the VA Northern California Healthcare System. She serves as Senior Director and Multiple Principal Investigator for The Bridge Center at PHI and CA Bridge, a program for which she is a cofounder. She is President for California Academy of Physician Associates and is a CE committee member and Presidential Taskforce member for ASAM. She also serves on the Board of Directors for the Society of Addiction Medicine PAs and the Medical Education Research Foundation. She has authored and co-authored multiple publications, the most recent detailing rural substance use navigation in her local rural hospital.
Lindsey Jennings, MD, MPH is an Associate Professor of Emergency Medicine at the Medical University of South Carolina (MUSC) and a board-certified specialist in both Emergency Medicine and Addiction Medicine. She has dedicated her career to expanding access to opioid use disorder (OUD) treatment in emergency department settings, with a particular focus on buprenorphine initiation, peer recovery support services, and linkage to care. She brings both research expertise and frontline clinical experience to her role on the Code Recover Advisory Board.
Phillip Moschella, MD, PhD, is a board-certified Emergency Physician Scientist with an extensive background in cellular signaling. He is a full-time clinician, Clinical Associate Professor and the Associate Research Director for the Department of Emergency Medicine for Prisma Health-Upstate. His primary research emphasis surrounds HIV and HCV recognition, and linkage to care from the emergency department (ED), with several publications in top-tier emergency medicine journals. He has expanded his research interests into substance use disorders and specifically opioids. He is the PI on a large ($1.5 million over 3 years) grant from SAMHSA to evaluate the use of Alternatives to Opioids in the ED and is Co-I on two Gilead Focus Awards. He has recently published an exciting systematic review on the effects of peer-recovery services in the ED and on his alternatives to opioids project. He oversees SBIRT programs within five emergency departments within Prisma Health-Upstate which include MAT initiation. He is also part of the first pre-hospital MAT initiation program alongside Community Paramedic linkage to care and treatment for HCV across the Upstate region of South Carolina in Greenville, Pickens, Spartanburg and Oconee counties.
Nasir Naqvi, MD, PhD, is a board-certified addiction psychiatrist. He is the Program Director for the Addiction Psychiatry Fellowship at Columbia University and NY State Psychiatric Institute, where he is also a translational cognitive neuroscientist studying the neural mechanisms of behavior change in alcohol use disorder by combining clinical and neuroimaging methods. He is also the Director of the Columbia/NYSPI Gambling Disorder Clinic. Dr. Naqvi also provides clinical care for patients with SUD and co-occurring psychiatric disorders in a number of public psychiatric settings.
